Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009.

PloS one - 10 Dec 2010

Jain Vivek, Liegler Teri, Vittinghoff Eric, Hartogensis Wendy, Bacchetti Peter, Poole Lauren, Loeb Lisa, Pilcher Christopher D, Grant Robert M, Deeks Steven G, Hecht Frederick M

Abstract excerpt

BACKGROUND: Transmitted HIV-1 drug resistance (TDR) is an ongoing public health problem, representing 10-20% of new HIV infections in many geographic areas. TDR usually arises from two main sources: individuals on antiretroviral therapy (ART) who are failing to achieve virologic suppression, and individuals who acquired TDR and transmit it while still ART-naïve. TDR rates can be impacted when novel antiretroviral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Models, Statistical

Share to Odds Ratio

Share to San Francisco

Source

Open in PubMed Open full text

Identifiers

PMID: 21170322
DOI: 10.1371/journal.pone.0015510
PMCID: PMC3000814

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009.PMID 21170322Read ↗

Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.Semantic proximity Read ↗

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.Semantic proximity Read ↗

Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations.Semantic proximity Read ↗

Prevalence of Antiretroviral Drug Resistance Mutations in HIV Seropositive Patients from an Outpatient Clinic of a Large University Hospital from São Paulo, Brazil.Semantic proximity Read ↗

Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-2018.Semantic proximity Read ↗

Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006.Semantic proximity Read ↗

[Prevalence of transmitted drug resistance in HIV-infected treatment-naive patients in Chile].Semantic proximity Read ↗

Epidemiology of transmitted drug resistance in chronically HIV-infected patients in Germany: the RESINA study 2001-2009.Semantic proximity Read ↗

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study CohortSemantic proximity Read ↗

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA PanelSemantic proximity Read ↗

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.Semantic proximity Read ↗

Increasing prevalence of HIV-1 Transmitted Drug Resistance in Portugal: implications for first line treatment recommendationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.